Full history for every metric is available with a Kvantra account

Stock profile
IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV)

Country: United States of AmericaSector: HealthcareIndustry: Medical - Diagnostics & ResearchExchange: NYSE
P/E TTM
30.4
History
P/E NTM
17.9
Market cap
41.29B
Currency USD
KvantraRankAbout38
IValue35
IIQuality33
IIIMomentum49
Current price
250.55 USD-2.83%
Close 19 Nov 2026
Interval
Benchmarks

Key financial summary

Financials in USD
202020212022202320242025TTM2026E
Total revenue$bn11.413.914.415.015.416.317.317.5
Operating profit$bn2.182.22
Net profit$bn0.280.971.091.361.371.361.392.25
EPS reported$7.848.23
Operating cashflow per share$15.4416.61
Capex per share$3.513.99
FCF per share$11.9312.62
Free cash flow$bn2.052.08
Net debt$bn13.813.6
Book value equity$bn6.506.66
Book value per share$37.4839.88
Number of sharesm173.5167
DPS (TTM paid)$0.000.00

Financial summary

Financials in USD
202020212022202320242025TTM2026E
Value
P/E TTMx28.7530.44
P/B LTMx5.966.20
P/S LTMx2.382.39
P/FCF LTMx18.8919.86
EV/EBITDA LTMx18.0215.20
EV/Sales LTMx3.253.17
Earnings Yield LTM%3.48%3.29%
FCF Yield%5.29%5.04%
Quality
ROE%20.91%21.82%
ROIC%7.85%7.83%
Operating margin%13.38%12.82%
Gross margin%33.29%33.07%
FCF/Sales%12.58%12.01%
Growth and momentum
EPS Growth YoY%+4.67%+12.89%
Sales Growth YoY%+5.87%+8.85%
Net Income Growth YoY%-0.95%+8.65%
FCF Growth%-2.98%-5.97%
Operating Profit Growth%-0.91%+1.74%
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx0.130.13
Net Debt/EBITDAx4.833.89
EBIT/Net interestx2.992.83
Net debt/market cap%35.64%33.05%
Net debt/Equityx2.122.05
Gross debt/equityx2.492.45

ETFs that hold IQVIA Holdings

FundTickerPosition#Weight
iShares Healthcare Innovation UCITS ETFHEAL.L41.71%
Lyrical U.S. Value Equity ETFLYR16.10%
VanEck Biotech ETFBBH74.33%
Thornburg American Opportunities FundTAOZ63.68%
Oakmark U.S. Concentrated ETFOAKL26.50%
Guggenheim Funds Trust - Guggenheim Ultra Short Income ETFGCSH92.27%

Funds with IQVIA Holdings among their ten largest holdings, largest fund first.

Price target estimates

Low estimate
High estimate
Price consensus
Last year average price target
Current price250.55 USD
Return Potential

Based on consensus from external analysts. Not Kvantra's opinion.

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

ESG

Metric202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating

Company overview

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Websiteiqvia.com
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

IQVIA Holdings Inc. (IQV)

IQV · NYSE · Healthcare
250.55 USD-2.83%
Sign up to track this stock
Benchmarks
KvantraRank38
Market cap41.29B
P/E NTM17.9
P/E TTM30.4
KvantraRank?38 / 100
Value
35
Quality
33
Momentum
49
Financialsin USD
20242025TTM2026E
ETFs that hold IQVIA Holdings
FundTickerPosition#Weight
iShares Healthcare Innovation UCITS ETFHEAL.L41.71%
Lyrical U.S. Value Equity ETFLYR16.10%
VanEck Biotech ETFBBH74.33%
Thornburg American Opportunities FundTAOZ63.68%
Oakmark U.S. Concentrated ETFOAKL26.50%
Guggenheim Funds Trust - Guggenheim Ultra Short Income ETFGCSH92.27%

Funds with IQVIA Holdings among their ten largest holdings, largest fund first.

Analyst target
Consensus
Current250.55 USD
Upside
Price consensus
Last year average price target
Current price250.55 USD
Return Potential

Consensus from external analysts. Not Kvantra's opinion.

Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

ESG
202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating
About

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Websiteiqvia.com
IndustryMedical - Diagnostics & Research
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free